tradmap

VERA Earnings Vera Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$5 -$2 $0 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$300M -$150M $0 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-116% -28% 60% 0% 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$3 -$2 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$121M -$61M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-27% -13% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–21 of 21
Q2 20262026-06-30-3.222026-08-1010-Q
Q1 20262026-03-31-1.692026-05-0710-Q
FY 20252025-12-31-4.662026-02-2610-K
Q3 20252025-09-30-3.272025-11-0510-Q
Q2 20262025-06-30-2.012026-08-1010-Q
Q1 20262025-03-31-0.812026-05-0710-Q
FY 20252024-12-31-2.752026-02-2610-K
Q3 20252024-09-30-2.032025-11-0510-Q
Q2 20252024-06-30-1.172025-08-0510-Q
Q1 20252024-03-31-0.562025-05-0710-Q
FY 20252023-12-31-2.252026-02-2610-K
Q3 20242023-09-30-1.672024-11-0710-Q
Q2 20242023-06-30-1.232024-08-0810-Q
Q1 20242023-03-31-0.802024-05-1010-Q
FY 20232022-12-31-3.352024-03-2710-K
Q3 20232022-09-30-2.162023-11-0910-Q
Q2 20232022-06-30-1.242023-08-1010-Q
Q1 20232022-03-31-0.712023-05-1110-Q
FY 20222021-12-31-2.432023-03-2810-K
Q3 20222021-09-30-1.462022-11-0910-Q
Q2 20222021-06-30-1.492022-08-1010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.